Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis
Receptor-mediated transcytosis (RMT) is used to enhance the delivery of monoclonal antibodies (mAb) into the central nervous system (CNS). While the binding to endogenous receptors on the brain capillary endothelial cells (BCECs) may facilitate the uptake of mAbs in the brain, a strong affinity for...
Main Authors: | Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Wanying Zhang, Matthew Burrell, Carl I. Webster, Dhaval K. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1874121 |
Similar Items
-
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
by: Laura Rué, et al.
Published: (2023-06-01) -
Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
by: Demi M. Castellanos, et al.
Published: (2020-09-01) -
Integrin α2β1-targeting ferritin nanocarrier traverses the blood–brain barrier for effective glioma chemotherapy
by: Chiun-Wei Huang, et al.
Published: (2021-06-01) -
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
by: Arsalan S. Haqqani, et al.
Published: (2024-03-01) -
Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer’s disease mice measured by high cut-off microdialysis
by: Ulrika Julku, et al.
Published: (2022-12-01)